Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9425223rdf:typepubmed:Citationlld:pubmed
pubmed-article:9425223lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C1710263lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C0752125lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C1705914lld:lifeskim
pubmed-article:9425223lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:9425223pubmed:issue2lld:pubmed
pubmed-article:9425223pubmed:dateCreated1998-3-17lld:pubmed
pubmed-article:9425223pubmed:abstractTextSpinocerebellar ataxia 7 (SCA7) is a neurodegenerative disorder characterized by degeneration of the cerebellum, brainstem and retina. The gene responsible for SCA7, located on chromosome 3p, recently was cloned and shown to contain a CAG repeat in the coding region of the gene, that is expanded in SCA7 patients of French origin. We examined the SCA7 repeat region in four Swedish SCA7 families as well as in 57 healthy controls. All Swedish SCA7 patients exhibited expanded CAG repeats with a strong negative correlation between repeat size and age of onset. The repeat length in SCA7 patients ranged from 40 to >200 repeats. The largest expansion was observed in a juvenile case with an age of onset of 3 months, and represents the longest polyglutamine stretch ever reported. In patients with 59 repeats or more, visual impairment was the most common initial symptom observed, while ataxia predominates in patients with <59 repeats. Two of the Swedish SCA7 families analysed in this study were shown to be related genealogically. The other two SCA7 families could not be traced back to a common ancestor. All four families shared the same allele on the disease chromosome at a locus closely linked to SCA7, suggesting the possibility of a founder effect in the Swedish population.lld:pubmed
pubmed-article:9425223pubmed:languageenglld:pubmed
pubmed-article:9425223pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9425223pubmed:citationSubsetIMlld:pubmed
pubmed-article:9425223pubmed:statusMEDLINElld:pubmed
pubmed-article:9425223pubmed:monthFeblld:pubmed
pubmed-article:9425223pubmed:issn0964-6906lld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:HolmgrenGGlld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:HolmbergMMlld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:JohanssonJJlld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:BriceAAlld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:SandgrenOOlld:pubmed
pubmed-article:9425223pubmed:authorpubmed-author:ForsgrenLLlld:pubmed
pubmed-article:9425223pubmed:issnTypePrintlld:pubmed
pubmed-article:9425223pubmed:volume7lld:pubmed
pubmed-article:9425223pubmed:ownerNLMlld:pubmed
pubmed-article:9425223pubmed:authorsCompleteYlld:pubmed
pubmed-article:9425223pubmed:pagination171-6lld:pubmed
pubmed-article:9425223pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:meshHeadingpubmed-meshheading:9425223-...lld:pubmed
pubmed-article:9425223pubmed:year1998lld:pubmed
pubmed-article:9425223pubmed:articleTitleExpanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation.lld:pubmed
pubmed-article:9425223pubmed:affiliationDepartment of Clinical Genetics, University Hospital of Umeâ, S-90185 Umeâ, Sweden.lld:pubmed
pubmed-article:9425223pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9425223pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9425223pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9425223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9425223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9425223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9425223lld:pubmed